Literature DB >> 21617727

Trabectedin-related rhabdomyolysis: an uncommon but fatal toxicity.

Aikaterini Stoyianni1, Nikolaos Kapodistrias, Eleutherios Kampletsas, George Pentheroudakis, Nicholas Pavlidis.   

Abstract

Rhabdomyolysis is defined as the dissolution of striped muscle characterized by the leakage of intracellular muscle components into the circulation, which can ultimately lead to renal failure with a possible fatal outcome. Trabectedin is a potential cause of rhabdomyolysis. Herein, we describe a case of rhabdomyolysis in a female patient with recurrent metastatic leiomyosarcoma of the uterus and who had full recovery, and we review the already published cases in order to identify a common pattern of emergence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21617727     DOI: 10.1177/030089161109700223

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  3 in total

1.  Association of creatine kinase and skin toxicity in phase I trials of anticancer agents.

Authors:  V Moreno Garcia; P Thavasu; M Blanco Codesido; L R Molife; J Vitfell Pedersen; M Puglisi; B Basu; K Shah; J Iqbal; J S de Bono; S B Kaye; U Banerji
Journal:  Br J Cancer       Date:  2012-10-25       Impact factor: 7.640

2.  Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedin.

Authors:  Sabino Strippoli; Vito Lorusso; Anna Albano; Michele Guida
Journal:  BMC Complement Altern Med       Date:  2013-07-30       Impact factor: 3.659

Review 3.  Drug induced rhabdomyolysis.

Authors:  Martin Hohenegger
Journal:  Curr Opin Pharmacol       Date:  2012-05-05       Impact factor: 5.547

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.